Helen Elizabeth Hanby
Director/Board Member at NIGHTSTAR THERAPEUTICS PLC
Helen Elizabeth Hanby active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NIGHTSTAR THERAPEUTICS PLC | Director/Board Member | 2019-06-06 | - |
| Corporate Secretary | 2019-08-07 | - | |
Tungsten Bidco Ltd.
 Tungsten Bidco Ltd. Financial ConglomeratesFinance Founded in 2019, Tungsten Bidco Ltd. is a British company that functions as an investment holding company. Part of Biogen, Inc., the company is based in Maidenhead, UK. | Director/Board Member | 2019-06-03 | - |
| Corporate Secretary | 2019-08-07 | - | |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Director/Board Member | 2019-06-06 | - |
| Corporate Secretary | 2019-08-07 | - |
Career history of Helen Elizabeth Hanby
Statistics
International
| United Kingdom | 4 |
Operational
| Director/Board Member | 3 |
| Corporate Secretary | 3 |
Sectoral
| Health Services | 2 |
| Health Technology | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Health Services |
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nightstar Therapeutics Ltd. is a clinical-stage gene therapy. It engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded by Robert MacLaren, Miguel Seabra and Matthew During in 2014 and is headquartered in London, the United Kingdom. | Health Technology |
Tungsten Bidco Ltd.
Tungsten Bidco Ltd. Financial ConglomeratesFinance Founded in 2019, Tungsten Bidco Ltd. is a British company that functions as an investment holding company. Part of Biogen, Inc., the company is based in Maidenhead, UK. | Finance |